Action IKNA IKENA ONCOLOGY, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Ikena Oncology, Inc.

Actions

IKNA

US45175G1085

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 01/07/2024 		Varia. 5j. Varia. 1 janv.
1,65 USD 0,00% Graphique intraday de Ikena Oncology, Inc. -1,79% -16,24%
29/05 IKENA ONCOLOGY, INC. : HC Wainwright toujours à l'achat ZM
29/05 IKENA ONCOLOGY, INC. : Wedbush neutre sur le dossier ZM

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
UPDATE – Ikena Oncology Announces Strategic Update
GL
Ikena Oncology Announces Strategic Update
GL
Ikena Oncology Announces Strategic Update
AQ
Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
GL
Ikena Oncology : Corporate Presentation - April 2024
PU
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum
GL
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum
AQ
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
GL
Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference
GL
Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer
GL
Ikena Oncology Outlines Key Priorities and Provides Corporate Updates
GL
Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results
GL
Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results
AQ
Ikena Oncology to Present at Multiple November 2023 Investor Conferences
GL
Ikena Oncology to Present at Multiple November 2023 Investor Conferences
AQ
Ikena Oncology : Corporate Presentation - Fall 2023
PU
Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Ikena Oncology Inc. (NASDAQ: IKNA)
PR
Ikena Oncology to Participate in September 2023 Investor Conferences
GL
Ikena Oncology : Corporate Presentation - Summer 2023
PU
Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate Update
GL
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action IKNA
  4. Actualités Ikena Oncology, Inc.
  5. Communiqués